Search for a report

NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

The North America hormone replacement therapy market is set to record a CAGR of 7.47% during the forecast period, 2021-2028. The well-established healthcare system demand for hormone replacement therapy (HRT) and the implementation of regulations with regard to the hormone are primary growth drivers.

NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

North America Hormone Replacement Therapy Market by Therapy Type (Estrogen Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy) Market by Indication (Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism, Other Indications) Market by Route of Administration (Oral, Parenteral, Transdermal, Other Route of Administrations) by Geography.

Request free sample

The North America hormone replacement therapy market is set to record a CAGR of 7.47% during the forecast period, 2021-2028. The well-established healthcare system demand for hormone replacement therapy (HRT) and the implementation of regulations with regard to the hormone are primary growth drivers.north-america-hormone-replacement-therapy-market

To learn more about this report, request a free sample copy

The North America hormone replacement therapy market growth analysis includes the assessment of the United States and Canada. In the United States, the approval of several HRT drugs drives the market growth. For instance, recombinant human parathyroid hormone (1-84) was approved for use by the US FDA for treating chronic hypoparathyroidism. The sales of combined hormonal contraceptives are more than $4 billion every year. Several hormonal replacement therapy drugs were approved in 2018 and 2019. Furthermore, the rising elderly population leads to an increased incidence rate of disorders like hypothyroidism, hypogonadism, and menopause. Also, the presence of many alternatives and the reimbursement of treatment costs propel market growth in the US.

Pfizer Inc is a biopharmaceutical company that discovers, manufactures, and markets vaccines, medicines, and consumer healthcare products. It provides products for the treatment of cardiovascular, respiratory, tissue repair, women’s health diseases, etc. Its innovative health segment contributed majorly to its revenue stream. The company has operations across Africa, the Middle East, Asia-Pacific, and the Americas, with headquarters in New York, the US.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVAILING AWARENESS ABOUT POST-MENOPAUSAL ISSUES AMONG WOMEN
        • INCIDENCE OF HORMONAL DISORDERS
        • PRODUCT LAUNCHES BY MAJOR PLAYERS
      • KEY RESTRAINTS
        • ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
        • HIGH COST OF TREATMENT
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    3. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    4. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • AMGEN
        • ANI PHARMACEUTICALS
        • BAYER AG
        • ELI LILLY & COMPANY
        • GENENTECH INC
        • IPSEN
        • MERCK KGAA
        • NOVARTIS AG
        • NOVEN PHARMACEUTICALS INC
        • NOVO NORDISK A/S
        • PFIZER INC
        • VIATRIS INC (MYLAN NV)

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – HORMONE REPLACEMENT THERAPY

    TABLE 2: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, IN 2020

    FIGURE 6: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, IN 2020

    FIGURE 12: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, IN 2020

    FIGURE 18: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTE OF ADMINISTRATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 23: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: CANADA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    2. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    3. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now